In Stock
Glimepiride + Metformin Tablets
Glimepiride + Metformin 2mg + 500mg | Anti-Diabetic Combination | Tablets
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic composition: Glimepiride 2 mg + Metformin Hydrochloride 500 mg. This combination contains a sulfonylurea (glimepiride), which stimulates insulin release, and metformin, a biguanide that reduces glucose production by the liver and improves insulin sensitivity. This document is for general education only and does not replace the approved product leaflet or advice from a qualified healthcare professional. The metformin formulation (immediate-release or modified-release) must be confirmed from the exact product pack.
Product Introduction
Glimepiride 2 mg + Metformin Hydrochloride 500 mg tablets are prescribed to help control blood glucose in adults with type 2 diabetes when a clinician considers both medicines appropriate. Glimepiride increases insulin release from the pancreas, while metformin lowers glucose production by the liver and helps the body respond better to insulin. The combination is used with a suitable meal plan, physical activity and regular blood-glucose monitoring.
1. Uses
Used to improve blood-glucose control in adults with type 2 diabetes when diet, exercise and the clinician’s treatment plan require both medicines.
May be prescribed when treatment with a single medicine is not providing adequate control or when a clinician decides a combination is appropriate.
It is not used to treat type 1 diabetes or diabetic ketoacidosis.
The combination is not suitable for everyone; kidney function, liver function, meal patterns and other medical conditions must be assessed.
2. Benefits
Combines two complementary mechanisms to help lower blood glucose.
May improve overall glucose control when used as prescribed with diet, physical activity and monitoring.
A fixed-dose combination may reduce the number of separate tablets a person needs to take.
Benefits vary by person. Glimepiride can cause hypoglycaemia, while metformin commonly causes gastrointestinal effects and may not be suitable in severe kidney impairment. The clinician should assess the balance of benefits and risks.
3. Side Effects
Possible side effects include:
Low blood sugar (hypoglycaemia) from glimepiride: sweating, shaking, hunger, headache, dizziness, palpitations, confusion or blurred vision. Severe cases can cause seizures or loss of consciousness.
Metformin-related digestive effects: nausea, diarrhoea, vomiting, abdominal discomfort, gas or reduced appetite.
Metallic or altered taste.
Low vitamin B12 levels with long-term metformin use in some people.
Rare but serious risks include metformin-associated lactic acidosis, especially in people with significant kidney impairment or severe illness, and severe or prolonged hypoglycaemia from glimepiride. Seek urgent medical care for unusual severe weakness, muscle pain, rapid/deep breathing, unusual sleepiness or feeling very cold; or for severe low blood sugar, unconsciousness or seizures.
If low blood sugar is suspected and the person is awake and able to swallow safely, follow the hypoglycaemia plan provided by their healthcare team; fast-acting glucose is commonly used. If the person is unconscious, having a seizure or unable to swallow safely, do not give food or drink by mouth—seek emergency medical help.
4. Safety Advice
Take only as prescribed. Do not change the dose or stop treatment without consulting the prescriber.
Take the medicine with a meal as directed on the exact product leaflet; do not skip or delay meals because glimepiride can cause low blood sugar.
Kidney function should be assessed before and during treatment because metformin may not be suitable in severe kidney impairment and the dose may need review.
Tell your healthcare professional if you have liver disease, kidney disease, severe infection, dehydration, heart or breathing problems, or a history of lactic acidosis.
Avoid excessive alcohol, which can increase the risk of lactic acidosis and make blood glucose less predictable.
If you have persistent vomiting, diarrhoea, fever or cannot maintain fluids, contact a healthcare professional promptly. Ask for a sick-day plan; temporary interruption may be advised.
Tell your clinician before an X-ray or scan using injected iodinated contrast or before major surgery; they will advise whether treatment needs to be paused.
Older adults and people with irregular food intake may have a higher risk of low blood sugar.
Tell your healthcare professional if you are pregnant, planning pregnancy or breastfeeding; treatment may need to be reviewed.
Monitor blood glucose as advised and attend scheduled kidney-function and other medical reviews.
Keep out of reach of children and store according to the package instructions.
5. How It Works
Glimepiride stimulates pancreatic beta cells to release insulin, helping reduce blood glucose. Metformin works mainly by reducing glucose production by the liver, improving insulin sensitivity and reducing some intestinal glucose absorption. Together, these actions can improve glucose control, but the insulin-releasing effect of glimepiride increases the risk of hypoglycaemia, especially when meals are missed.
6. How to Use
Follow the prescription label and patient leaflet supplied with the exact product.
Take the tablet with a meal, commonly breakfast or the first main meal, if this matches the product leaflet and your prescriber’s directions.
Swallow with water. Do not crush, split or chew a modified-release tablet unless the exact product leaflet explicitly permits it.
The 2 mg + 500 mg strength may not be appropriate for everyone; the prescriber individualizes treatment based on glucose control, kidney function, tolerability and other medicines.
If you miss a dose, follow the leaflet or ask a pharmacist/doctor. Do not take a double dose to make up for a missed dose.
If you take more than prescribed, seek urgent medical advice, especially because glimepiride-related hypoglycaemia can be severe or prolonged.
Do not stop treatment because you feel well; discuss any changes with your clinician.
7. Quick Tips
Take the tablet with the meal and at the time specified by your prescriber.
Do not skip meals and learn the warning signs of low blood sugar.
Keep a fast-acting source of glucose available if advised by your healthcare team.
Monitor blood glucose and HbA1c as recommended.
Attend kidney-function monitoring and ask whether vitamin B12 testing is appropriate during long-term metformin treatment.
Tell your doctor or pharmacist about all prescription medicines, over-the-counter medicines, supplements and herbal products.
Seek urgent help for severe low blood sugar or symptoms that may suggest lactic acidosis.
Do not share your medicine with anyone else.
8. Drug Interactions
Tell your doctor and pharmacist about all medicines, vitamins, supplements and herbal products you use. Some medicines can change blood glucose, affect kidney function or increase the risk of side effects.
Insulin and other glucose-lowering medicines: may increase the risk of hypoglycaemia.
Some antibiotics, antifungals, NSAID pain relievers and other medicines may increase or alter glimepiride’s effect; professional review may be needed.
Diuretics, some blood-pressure medicines and NSAIDs may affect kidney function in certain circumstances, which can influence metformin safety.
Iodinated contrast agents used for certain scans may require temporary interruption of metformin and kidney-function assessment according to clinical guidance.
Alcohol: excessive intake increases the risk of metformin-associated lactic acidosis and may affect glucose control.
Some medicines, including carbonic anhydrase inhibitors such as topiramate or acetazolamide, may increase lactic-acidosis risk in certain circumstances.
Do not start, stop or change any medicine without professional advice.
| Product Name | Glimepiride + Metformin Tablets |
| Category | All Medicines, Anti Diabetic |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 2mg + 500mg |
|---|---|
| Type | Combination |
| Form | Tablets |
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
